Last updated on February 2018

Effect and Efficacy of Onyx Zotarolimus-eluting Stent for Coronary Atherosclerosis

Brief description of study

The objectives of this study are

  1. To establish a prospective registry of the whole patients who received percutaneous coronary intervention with Resolute Onyx stent.
  2. To evaluate the long-term efficacy and safety of coronary stenting with the Resolute Onyx stent.
  3. To compare the long-term efficacy and safety of coronary stenting between the Resolute Onyx stent and other contemporary drug-eluting stents which had established their own registry.

Detailed Study Description

Secondary endpoints are

  1. Stent thrombosis-24 hours(acute), 30 days(subacute), 1 year(late), every 1 year till 3 years(very-late) after index PCI (percutaneous coronary intervention),
  2. Target vessel failure
  3. Composite rate of cardiac death and any MI, 3 years
  4. Composite rate of all death and any MI
  5. Composite rate of all death, any MI, and any repeat revascularization
  6. Compliance and therapy interruptions with prescribed adjunctive antiplatelet therapy
  7. Clinical device and procedural success

Clinical Study Identifier: NCT03151018

Find a site near you

Start Over